Status:

TERMINATED

Fecal Microbiota Transplantation for Treatment of Gastrointestinal Dysbiosis or Clearance of ARO

Lead Sponsor:

Vancouver Island Health Authority

Conditions:

Dysbiosis

Antimicrobial Resistant Organism

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The objective of this study is to assess the efficacy of FMTs via rectal administration for 1) symptom improvement in individuals with a formal diagnosis of dysbiosis due to active inflammatory bowel ...

Detailed Description

Fecal Microbiota Transplantation (FMT), which had been predominantly utilized by the veterinarians until late 1990's has generated a significant interest for its potential use in various gastrointesti...

Eligibility Criteria

Inclusion

  • Age 18 years or older.
  • Able to provide informed consent.
  • Willing and able to comply with all the required study procedures.
  • Rectally colonized with antimicrobial resistant organisms: Extended-spectrum of beta-lactamase, Carbapenem resistant, vancomycin resistant enterococci

Exclusion

  • Planned or actively taking another investigational product
  • Patients with neutropenia with absolute neutrophil count \<0.5 x 109/L
  • Evidence of toxic megacolon or gastrointestinal perforation on abdominal x-ray
  • Peripheral white blood cell count \> 30.0 x 109/L AND temperature \> 38.0 ºC
  • Active gastroenteritis due to Salmonella, Shigella, shiga toxin-producing E. coli, Yersinia or Campylobacter.
  • Unable to tolerate FMT or enema for any reason.
  • Requiring systemic antibiotic therapy at the time of FMT.
  • Actively taking Saccharomyces boulardii or other probiotic; yogurt is allowed
  • Severe underlying disease such that the patient is not expected to survive for at least 30 days.
  • History of severe allergy to any food

Key Trial Info

Start Date :

February 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 8 2020

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT03834051

Start Date

February 1 2019

End Date

July 8 2020

Last Update

March 18 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vancouver Island Health Authority

Victoria, British Columbia, Canada, V8R 1J8